Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
mTOR as a potential treatment target for epilepsy
Michael Wong
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Institute of Clinical and Translational Sciences (ICTS)
DBBS - Neurosciences
Section of Pediatric Epilepsy
Intellectual and Developmental Disabilities Research Center (IDDRC)
Hope Center for Neurological Disorders
Research output
:
Contribution to journal
›
Article
›
peer-review
16
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'mTOR as a potential treatment target for epilepsy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Mammalian Target of Rapamycin (mTOR)
100%
Epilepsy
100%
Targeted Treatment
100%
Potential Treatments
100%
MTOR Inhibitor
80%
Tuberous Sclerosis Complex
40%
Seizure
40%
Clinical Data
40%
Antiepileptogenic
40%
Brain Injury
20%
Effective Therapy
20%
Current Treatment
20%
Disease-modifying Therapy
20%
Full Potential
20%
Number of Factors
20%
Mechanism of Action
20%
Clinical Research
20%
Novel Therapeutic Targets
20%
Complex Patients
20%
Neurotransmitter Receptors
20%
Genetic Epilepsy
20%
Mammalian Target of Rapamycin Pathway
20%
Acquired Epilepsy
20%
Anion Receptor
20%
Seizure Medications
20%
Pharmacology, Toxicology and Pharmaceutical Science
Mammalian Target of Rapamycin
100%
Mammalian Target of Rapamycin Inhibitor
100%
Tuberous Sclerosis
50%
Brain Injury
25%
Ion Channel
25%
Clinical Research
25%
Neurotransmitter Receptor
25%
Diseases
25%